← Leaderboards
Andrey A Parkhitko
University Of Pittsburgh At Pittsburgh
$3,881,772
Attributed
$4,536,675
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,536,675 · 6
By mechanism
R35$1,840,000 · 1
R01$1,309,806 · 1
R00$871,361 · 1
R03$318,000 · 2
K99$197,508 · 1
Top collaborators
- Marc Tatar3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joel S Greenberger$22,565,586
- Jian Yu$10,881,915
- Jill M Siegfried$10,296,579
- Leaf Huang$16,174,553
- Hannah Rabinowich$5,303,204
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsTissuesAffectAgingMethionineMethionine Metabolism PathwayMetabolic PathwayDrosophila GenusInsightGeneticNovel TherapeuticsPathologicProductionStressNerve DegenerationMitochondriaLongevityHealthspanAge RelatedHuman PathologyResponseMethyltransferaseAlzheimer&AposCell Physiology
Grant awards (18)
Methionine Cycle as a Mechanistic Hub for the Hallmarks of Aging$426,289
R01 · FY2025 · AG
Deciphering the crosstalk between methionine metabolism and methyltransferases in health and disease$397,500
R35 · FY2025 · GM · contact PI
Combined targeting of synthetic lethal partners in RB1-deficient cells$79,500
R03 · FY2025 · CA · contact PI
Methionine Cycle as a Mechanistic Hub for the Hallmarks of Aging$434,989
R01 · FY2024 · AG
Deciphering the crosstalk between methionine metabolism and methyltransferases in health and disease$397,500
R35 · FY2024 · GM · contact PI
Combined targeting of synthetic lethal partners in RB1-deficient cells$79,500
R03 · FY2024 · CA · contact PI
Methionine Cycle as a Mechanistic Hub for the Hallmarks of Aging$448,528
R01 · FY2023 · AG
Deciphering the crosstalk between methionine metabolism and methyltransferases in health and disease$397,500
R35 · FY2023 · GM · contact PI
Deciphering the crosstalk between methionine metabolism and methyltransferases in health and disease$250,000
R35 · FY2023 · GM · contact PI
Tyrosine degradation pathway in mitochondrial dysfunction and aging$79,500
R03 · FY2023 · AG · contact PI
Deciphering the crosstalk between methionine metabolism and methyltransferases in health and disease$397,500
R35 · FY2022 · GM · contact PI
Studying methionine flux and its role in aging and neurodegeneration$248,999
R00 · FY2022 · AG · contact PI
Studying methionine flux and its role in aging and neurodegeneration$124,698
R00 · FY2022 · AG · contact PI
Tyrosine degradation pathway in mitochondrial dysfunction and aging$79,500
R03 · FY2022 · AG · contact PI
Studying methionine flux and its role in aging and neurodegeneration$248,665
R00 · FY2021 · AG · contact PI
Studying methionine flux and its role in aging and neurodegeneration$248,999
R00 · FY2020 · AG · contact PI
Studying methionine flux and its role in aging and neurodegeneration$98,754
K99 · FY2019 · AG · contact PI
Studying methionine flux and its role in aging and neurodegeneration$98,754
K99 · FY2018 · AG · contact PI